Heinz Schmidli works as an Executive Director in the Statistical Methodology group at Novartis, Basel, Switzerland. Since he joined the group in 2007, he contributes to the development of innovative approaches for the design and analysis of clinical trials, with a focus on Bayesian methods. In 2012 he received the Paul-Martini-Prize of the GMDS (jointly with Tim Friede), and in 2020 the Novartis distinguished scientist award.